Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
503
Total raised
£3.8B
disclosed amounts
This month
£36.9M
raised so far
The company secured backing from the Low Carbon Innovation Fund and Angel CoFund to expand its distribution network and ready its Shepherd monitor for launch.
"I was keen to find a highly innovative, original, self-sufficient company that was also turning a profit. Bactest is changing the face of the world as we know it, so I feel it is the worthy winner of the Business SME of the Year award"
The funding round includes backing from The North West Fund for Biomedical, Innovate UK, and London Business Angels.
The funding round was led by Finance Wales and the Angel CoFund alongside private investors to establish a new administration and sales team.
The seed round was cornerstoned by a £125k investment from Angels in the City and London Business Angels syndicate members.
"Our team founded BreakBad to change the way we understand, measure and influence our health from tracking symptomatic metrics like calories and kilos to the causal metrics that drive our behaviour. We needed the funds to hire the talent required to embark on this exciting journey and pitched at Angels in the City. Huge thanks to Kayar Raghavan our lead investor and Andrew Dancer our board member who helped with fund raising and strategy respectively. The Angels in the City process was seamless and in less than 2 months, we have the funds and team to embark on this exciting journey."
Midven and angel investors back Health2Works with £251k to scale its NHS-aligned software tools.
"There is huge pressure on the NHS to save money and one of the ways it will do that is through technology innovation. After working with a number of NHS trusts, we already know of the benefits that apps and tools like Rally Round and Ollie bring in terms of empowering patients and increasing productivity. The funding we have received from Midven and our angel investors will enable us to progress to fully-commercialised, universal tools that will help NHS health care providers across the country."
